SOX7: Novel Autistic Gene Identified by Analysis of Multi-Omics Data

Background Genome-wide association studies and next generation sequencing data analyses based on DNA information have identified thousands of mutations associated with autism spectrum disorder (ASD). However, more than 99% of identified mutations are non-coding. Thus, it is unclear which of these mutations might be functional and thus potentially causal variants. Transcriptomic profiling using total RNA-sequencing has been one of the most utilized approaches to link protein levels to genetic information at the molecular level. The transcriptome captures molecular genomic complexity that the DNA sequence solely does not. Some mutations alter a gene’s DNA sequence but do not necessarily change expression and/or protein function. To date, few common variants reliably associated with the diagnosis status of ASD despite consistently high estimates of heritability. In addition, reliable biomarkers used to diagnose ASD or molecular mechanisms to define the severity of ASD do not exist. Objectives It is necessary to integrate DNA and RNA testing together to identify true causal genes and propose useful biomarkers for ASD. Methods We performed gene-based association studies with adaptive test using genome-wide association studies (GWAS) summary statistics with two large GWAS datasets (ASD 2019 data: 18,382 ASD cases and 27,969 controls [discovery data]; ASD 2017 data: 6,197 ASD cases and 7,377 controls [replication data]) which were obtained from the Psychiatric Genomics Consortium (PGC). In addition, we investigated differential expression for genes identified in gene-based GWAS with a RNA-seq dataset (GSE30573: 3 cases and 3 controls) using the DESeq2 package. Results We identified 5 genes significantly associated with ASD in ASD 2019 data (KIZ-AS1, p=8.67×10−10; KIZ, p=1.16×10−9; XRN2, p=7.73×10−9; SOX7, p=2.22×10−7; PINX1-DT, p=2.14×10−6). Among these 5 genes, gene SOX7 (p=0.00087), LOC101929229 (p=0.009), and KIZ-AS1 (p=0.059) were replicated in ASD 2017 data. KIZ (p=0.06) was close to the boundary of replication in ASD 2017 data. Genes SOX7 (p=0.0017, adjusted p=0.0085), LOC101929229 (also known as PINX1-DT, p=5.83×10−7, adjusted p=1.18×10−5), and KIZ (p=0.00099, adjusted p=0.0055) indicated significant expression differences between cases and controls in the RNA-seq data. SOX7 encodes a member of the SOX (SRY-related HMG-box) family of transcription factors pivotally contributing to determining of the cell fate and identity in many lineages. The encoded protein may act as a transcriptional regulator after forming a protein complex with other proteins leading to autism. Conclusion Gene SOX7 in the transcription factor family could be associated with ASD. This finding may provide new diagnostic and therapeutic strategies for ASD.

[1]  A. Baranova,et al.  Shared genetics between autism spectrum disorder and attention-deficit/hyperactivity disorder and their association with extraversion , 2022, Psychiatry Research.

[2]  H. Nicolini,et al.  Epigenome-Wide Analysis Reveals DNA Methylation Alteration in ZFP57 and Its Target RASGFR2 in a Mexican Population Cohort with Autism , 2022, Children.

[3]  Ana Rita Marques,et al.  Gene Variants Involved in Nonsense-Mediated mRNA Decay Suggest a Role in Autism Spectrum Disorder , 2022, Biomedicines.

[4]  Paul Theodor Pyl,et al.  Analysing high-throughput sequencing data in Python with HTSeq 2.0 , 2021, Bioinform..

[5]  Miguel E. Avila,et al.  Wnt/β-Catenin-Dependent Transcription in Autism Spectrum Disorders , 2021, Frontiers in Molecular Neuroscience.

[6]  E. Gozal,et al.  Potential crosstalk between sonic hedgehog‐WNT signaling and neurovascular molecules: Implications for blood–brain barrier integrity in autism spectrum disorder , 2021, Journal of neurochemistry.

[7]  F. Giuliano,et al.  Wnt/β-catenin pathway and cell adhesion deregulation in CSDE1-related intellectual disability and autism spectrum disorders , 2021, Molecular Psychiatry.

[8]  N. Wray,et al.  Investigating Shared Genetic Basis Across Tourette Syndrome and Comorbid Neurodevelopmental Disorders Along the Impulsivity-Compulsivity Spectrum , 2021, Biological Psychiatry.

[9]  G. Blatt,et al.  Increased Dopamine Type 2 Gene Expression in the Dorsal Striatum in Individuals With Autism Spectrum Disorder Suggests Alterations in Indirect Pathway Signaling and Circuitry , 2020, Frontiers in Cellular Neuroscience.

[10]  Md. Rezanur Rahman,et al.  Comprehensive Analysis of RNA-Seq Gene Expression Profiling of Brain Transcriptomes Reveals Novel Genes, Regulators, and Pathways in Autism Spectrum Disorder , 2020, Brain sciences.

[11]  L. D. Costa,et al.  Vascular contributions to 16p11.2 deletion autism syndrome modeled in mice , 2020, Nature Neuroscience.

[12]  Juan Pablo Arcon,et al.  Impact of DNA methylation on 3D genome structure , 2020, Nature Communications.

[13]  N. Hoertel,et al.  Combining multivariate genomic approaches to elucidate the comorbidity between ASD and ADHD , 2020, bioRxiv.

[14]  A. Malik,et al.  Comprehensive transcriptomic profiling reveals SOX7 as an early regulator of angiogenesis in hypoxic human endothelial cells , 2020, The Journal of Biological Chemistry.

[15]  R. Kizek,et al.  Oxidative Stress in Autism Spectrum Disorder , 2020, Molecular Neurobiology.

[16]  Alireza F. Siahpirani,et al.  Transcriptome-wide transmission disequilibrium analysis identifies novel risk genes for autism spectrum disorder , 2019, bioRxiv.

[17]  M. Owen,et al.  Novel Insight Into the Etiology of Autism Spectrum Disorder Gained by Integrating Expression Data With Genome-wide Association Statistics , 2018, Biological Psychiatry.

[18]  Á. Carracedo,et al.  Novel Gene-Based Analysis of ASD GWAS: Insight Into the Biological Role of Associated Genes , 2019, Front. Genet..

[19]  Gene W. Yeo,et al.  Disruption of RNA Metabolism in Neurological Diseases and Emerging Therapeutic Interventions , 2019, Neuron.

[20]  M. Butler,et al.  GeneAnalytics Pathways and Profiling of Shared Autism and Cancer Genes , 2019, International journal of molecular sciences.

[21]  John P. Rice,et al.  Identification of common genetic risk variants for autism spectrum disorder , 2019, Nature Genetics.

[22]  Matthew W. Mosconi,et al.  Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism , 2019, Cell.

[23]  Robert J. Weatheritt,et al.  Autism spectrum disorder: insights into convergent mechanisms from transcriptomics , 2018, Nature Reviews Genetics.

[24]  Y. Lecarpentier,et al.  PPARγ agonists: potential treatment for autism spectrum disorder by inhibiting the canonical WNT/β-catenin pathway , 2018, Molecular Psychiatry.

[25]  Joshua D. Eaton,et al.  An end in sight? Xrn2 and transcriptional termination by RNA polymerase II , 2018, Transcription.

[26]  T. Bourgeron,et al.  Both rare and common genetic variants contribute to autism in the Faroe Islands , 2018, bioRxiv.

[27]  Bin Guo,et al.  Statistical methods to detect novel genetic variants using publicly available GWAS summary data , 2018, Comput. Biol. Chem..

[28]  Hyung-Seok Kim,et al.  Sox7 promotes high-grade glioma by increasing VEGFR2-mediated vascular abnormality , 2018, The Journal of experimental medicine.

[29]  Alicia R. Martin,et al.  Elevated polygenic burden for autism is associated with differential DNA methylation at birth , 2017, bioRxiv.

[30]  Sven Sandin,et al.  The Heritability of Autism Spectrum Disorder , 2017, JAMA.

[31]  A. Lilly,et al.  SOX7 expression is critically required in FLK1-expressing cells for vasculogenesis and angiogenesis during mouse embryonic development , 2017, Mechanisms of Development.

[32]  Christopher S. Poultney,et al.  Meta-analysis of GWAS of over 16,000 individuals with autism spectrum disorder highlights a novel locus at 10q24.32 and a significant overlap with schizophrenia , 2017, Molecular Autism.

[33]  J. George,et al.  Single-cell transcriptomes identify human islet cell signatures and reveal cell-type–specific expression changes in type 2 diabetes , 2017, Genome research.

[34]  Luis de la Torre Ubieta,et al.  Genome-wide changes in lncRNA, splicing, and regional gene expression patterns in autism , 2016, Nature.

[35]  Luis de la Torre Ubieta,et al.  Genome-wide changes in lncRNA, splicing, and regional gene expression patterns in autism , 2016, Nature.

[36]  Karun K Singh,et al.  Wnt signaling networks in autism spectrum disorder and intellectual disability , 2016, Journal of Neurodevelopmental Disorders.

[37]  F. Middleton,et al.  A Comparative Review of microRNA Expression Patterns in Autism Spectrum Disorder , 2016, Front. Psychiatry.

[38]  T Grant Belgard,et al.  Genome-wide, integrative analysis implicates microRNA dysregulation in autism spectrum disorder , 2016, Nature Neuroscience.

[39]  Chulhee Choi,et al.  SoxF Transcription Factors Are Positive Feedback Regulators of VEGF Signaling. , 2016, Circulation research.

[40]  Måns Magnusson,et al.  MultiQC: summarize analysis results for multiple tools and samples in a single report , 2016, Bioinform..

[41]  Chuanlu Jiang,et al.  SOX7 is associated with the suppression of human glioma by HMG-box dependent regulation of Wnt/β-catenin signaling. , 2016, Cancer letters.

[42]  A. Packer Neocortical neurogenesis and the etiology of autism spectrum disorder , 2016, Neuroscience & Biobehavioral Reviews.

[43]  D. Geschwind,et al.  Advancing the understanding of autism disease mechanisms through genetics , 2016, Nature Medicine.

[44]  Wolf-Dietrich Heyer,et al.  Autism and Cancer Share Risk Genes, Pathways, and Drug Targets. , 2016, Trends in genetics : TIG.

[45]  P. Bolton,et al.  Heritability of autism spectrum disorders: a meta‐analysis of twin studies , 2015, Journal of child psychology and psychiatry, and allied disciplines.

[46]  Kathleen Campbell,et al.  Cell cycle networks link gene expression dysregulation, mutation, and brain maldevelopment in autistic toddlers , 2015, Molecular systems biology.

[47]  Jakob Grove,et al.  Genetic risk for autism spectrum disorders and neuropsychiatric variation in the general population , 2015, Nature Genetics.

[48]  Christopher S. Poultney,et al.  Insights into Autism Spectrum Disorder Genomic Architecture and Biology from 71 Risk Loci , 2015, Neuron.

[49]  T. Bourgeron From the genetic architecture to synaptic plasticity in autism spectrum disorder , 2015, Nature Reviews Neuroscience.

[50]  Elhanan Borenstein,et al.  The discovery of integrated gene networks for autism and related disorders , 2015, Genome research.

[51]  U. Müller,et al.  8p23.1 duplication syndrome: narrowing of critical interval to 1.80 Mbp , 2014, Molecular Cytogenetics.

[52]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[53]  Carson C Chow,et al.  Second-generation PLINK: rising to the challenge of larger and richer datasets , 2014, GigaScience.

[54]  Kathryn Roeder,et al.  Most genetic risk for autism resides with common variation , 2014, Nature Genetics.

[55]  David R. O'Brien,et al.  Cell Type-Specific Expression Analysis to Identify Putative Cellular Mechanisms for Neurogenetic Disorders , 2014, The Journal of Neuroscience.

[56]  C. Gillberg,et al.  Early Symptomatic Syndromes Eliciting Neurodevelopmental Clinical Examinations , 2013, TheScientificWorldJournal.

[57]  A. Kihara,et al.  A possible new mechanism for the control of miRNA expression in neurons , 2013, Experimental Neurology.

[58]  Jianxin Shi,et al.  Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs , 2013, Nature Genetics.

[59]  S. Gau,et al.  Increased gene expression of FOXP1 in patients with autism spectrum disorders , 2013, Molecular Autism.

[60]  P. Green,et al.  XRN 5'→3' exoribonucleases: structure, mechanisms and functions. , 2013, Biochimica et biophysica acta.

[61]  Stefan Liebner,et al.  Wnt signaling in the vasculature. , 2013, Experimental cell research.

[62]  W. Brown,et al.  Genes associated with autism spectrum disorder , 2012, Brain Research Bulletin.

[63]  D. Bentley,et al.  mRNA decapping factors and the exonuclease Xrn2 function in widespread premature termination of RNA polymerase II transcription. , 2012, Molecular cell.

[64]  Michael F. Walker,et al.  De novo mutations revealed by whole-exome sequencing are strongly associated with autism , 2012, Nature.

[65]  Yan Sun,et al.  Downregulating the Canonical Wnt/β-catenin Signaling Pathway Attenuates the Susceptibility to Autism-like Phenotypes by Decreasing Oxidative Stress , 2012, Neurochemical Research.

[66]  Bradley P. Coe,et al.  Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations , 2012, Nature.

[67]  O. Delaneau,et al.  A linear complexity phasing method for thousands of genomes , 2011, Nature Methods.

[68]  B. Crespi Autism and cancer risk , 2011, Autism research : official journal of the International Society for Autism Research.

[69]  Kathryn Roeder,et al.  Multiple Recurrent De Novo CNVs, Including Duplications of the 7q11.23 Williams Syndrome Region, Are Strongly Associated with Autism , 2011, Neuron.

[70]  Boris Yamrom,et al.  Rare De Novo and Transmitted Copy-Number Variation in Autistic Spectrum Disorders , 2011, Neuron.

[71]  K. Ohi,et al.  Gene expression analysis in lymphoblasts derived from patients with autism spectrum disorder , 2011, Molecular autism.

[72]  S. Horvath,et al.  Transcriptomic Analysis of Autistic Brain Reveals Convergent Molecular Pathology , 2011, Nature.

[73]  F. Johnson PinX1 the tail on the chromosome. , 2011, The Journal of clinical investigation.

[74]  Fuad G. Gwadry,et al.  Gene and miRNA expression profiles in autism spectrum disorders , 2011, Brain Research.

[75]  D. G. Pestov,et al.  5′-end surveillance by Xrn2 acts as a shared mechanism for mammalian pre-rRNA maturation and decay , 2010, Nucleic acids research.

[76]  Mark M. Davis,et al.  Cell type–specific gene expression differences in complex tissues , 2010, Nature Methods.

[77]  M. Beltrame,et al.  SoxF genes: Key players in the development of the cardio-vascular system. , 2010, The international journal of biochemistry & cell biology.

[78]  F. Barale,et al.  Serum levels of vascular endothelial growth factor and its receptors in patients with severe autism. , 2010, Clinical biochemistry.

[79]  A. Breman,et al.  Chromosome 8p23.1 deletions as a cause of complex congenital heart defects and diaphragmatic hernia , 2009, American journal of medical genetics. Part A.

[80]  E. Fombonne Epidemiology of Pervasive Developmental Disorders , 2009, Pediatric Research.

[81]  J. Rubenstein,et al.  Chromosome 8p as a potential hub for developmental neuropsychiatric disorders: implications for schizophrenia, autism and cancer , 2009, Molecular Psychiatry.

[82]  P. Donnelly,et al.  A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association Studies , 2009, PLoS genetics.

[83]  Joseph D. Buxbaum,et al.  Multiple rare variants in the etiology of autism spectrum disorders , 2009, Dialogues in clinical neuroscience.

[84]  Andrew P. McMahon,et al.  Canonical Wnt Signaling Regulates Organ-Specific Assembly and Differentiation of CNS Vasculature , 2008, Science.

[85]  D. Geschwind,et al.  Heterogeneous dysregulation of microRNAs across the autism spectrum , 2008, neurogenetics.

[86]  N. Shimizu,et al.  Two patients with atypical interstitial deletions of 8p23.1: Mapping of phenotypical traits , 2008, American journal of medical genetics. Part A.

[87]  S. Christian,et al.  Disruption of contactin 4 in three subjects with autism spectrum disorder , 2008, Journal of Medical Genetics.

[88]  M. Casanova,et al.  The Neuropathology of Autism , 2007, Brain pathology.

[89]  Miho Ohsugi,et al.  The Plk1 target Kizuna stabilizes mitotic centrosomes to ensure spindle bipolarity , 2006, Nature Cell Biology.

[90]  William J Walsh,et al.  Altered vascular phenotype in autism: correlation with oxidative stress. , 2006, Archives of neurology.

[91]  N. Proudfoot,et al.  Human 5′ → 3′ exonuclease Xrn2 promotes transcription termination at co-transcriptional cleavage sites , 2004, Nature.

[92]  W. McGinnis Oxidative stress in autism. , 2004, Alternative therapies in health and medicine.

[93]  A. Grodzinsky,et al.  Mechanical Compression of Cartilage Explants Induces Multiple Time-dependent Gene Expression Patterns and Involves Intracellular Calcium and Cyclic AMP* , 2004, Journal of Biological Chemistry.

[94]  K. Schilling,et al.  Developmental and cell type‐specific expression of the neuronal marker NeuN in the murine cerebellum , 2003, Journal of neuroscience research.

[95]  Christopher A Walsh,et al.  Characterization of Foxp2 and Foxp1 mRNA and protein in the developing and mature brain , 2003, The Journal of comparative neurology.

[96]  Thomas Bourgeron,et al.  Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism , 2003, Nature Genetics.

[97]  M. Katoh Expression of human SOX7 in normal tissues and tumors. , 2002, International journal of molecular medicine.

[98]  J. Cañizares,et al.  SOX7 transcription factor: sequence, chromosomal localisation, expression, transactivation and interference with Wnt signalling. , 2001, Nucleic Acids Research.

[99]  W. Akeson,et al.  Time‐dependent increases in type‐III collagen gene expression in medial collateral ligament fibroblasts under cyclic strains , 2000, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[100]  A. Bird,et al.  DNA methylation and chromatin structure , 1991, FEBS letters.

[101]  Howard Cedar,et al.  DNA methylation affects the formation of active chromatin , 1986, Cell.

[102]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[103]  Avner Schlessinger,et al.  ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI , 2012 .

[104]  Xi He,et al.  Wnt/ β -catenin signaling: components, mechanisms, and diseases , 2010 .

[105]  T. Bourgeron,et al.  Abnormal melatonin synthesis in autism spectrum disorders , 2008, Molecular Psychiatry.

[106]  T. Bourgeron,et al.  Linkage and association of the glutamate receptor 6 gene with autism , 2002, Molecular Psychiatry.